|
Vol. 9, Issue 7, 662-671, July 1999
LETTER
A 3-Mb High-Resolution BAC/PAC Contig of 12q22 Encompassing the 830-kb Consensus Minimal Deletion in Male Germ Cell Tumors
Vundavalli V.V.S.
Murty,1,5
Kate
Montgomery,2
Shipra
Dutta,1
Shashi
Bala,1
Beatrice
Renault,2
George J.
Bosl,3
Raju
Kucherlapati,2 and
Raju S.K.
Chaganti4
1 Department of Pathology, College of Physicians & Surgeons
of Columbia University, New York, New York 10032 USA;
2 Department of Molecular Genetics, Albert Einstein College of
Medicine, Bronx, New York 10461 USA; 3 Department of Medicine,
and 4 Laboratory of Cancer Genetics & Department of Human Genetics,
Memorial Sloan-Kettering Cancer Center, New York, New York 10021 USA
Cytogenetic and molecular genetic analyses have shown that the 12q22
region is recurrently deleted in male germ cell tumors (GCTs),
suggesting that this site may harbor a tumor suppressor gene (TSG).
Previous loss of heterozygosity (LOH) analyses identified a consensus
minimal deleted region between the markers D12S377 and
D12S296, and a YAC clone contig covering the region was
generated. Here, we describe a high-resolution sequence-ready physical
map of this contig covering a 3-Mb region. The map comprised of 52 cosmids, 49 PACs, and 168 BACs that were anchored to the previous YAC
contig; 99 polymorphic, nonpolymorphic, EST, and gene-based markers are
now placed on this map in a unique order. Of these, 61 markers were
isolated in the present study, including one that was polymorphic. In
addition, we have narrowed the minimal deletion to ~830 kb between
D12S1716 (proximal) and P382A8-AG (distal) by LOH
analysis of 108 normal-tumor DNAs from GCT patients using 21 polymorphic STSs. These physical and deletion maps should prove useful
for identification of the candidate TSG in GCTs, provide framework to
generate complete DNA sequence, and ultimately generate a gene map of
this segment of the chromosome 12.
[The sequence data described in this paper have been submitted to the
Genome Survey Sequence under accession nos. AQ254896-AQ254955 and
AQ269251-AQ269266. Online supplementary material is available at
http://www.genome.org]
5
Corresponding author.
9:662-671 ©1999 by Cold Spring Harbor Laboratory Press ISSN 1088-9051/99 $5.00

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Houldsworth, J. E. Korkola, G. J. Bosl, and R. S. K. Chaganti
Biology and Genetics of Adult Male Germ Cell Tumors
J. Clin. Oncol.,
December 10, 2006;
24(35):
5512 - 5518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Chatterjee, L. A. Shakes, D. K. Srivastava, D. M. Garland, K. R. Harewood, K. J. Moore, and J. S. Coren
Mutually exclusive recombination of wild-type and mutant loxP sites in vivo facilitates transposon-mediated deletions from both ends of genomic DNA in PACs
Nucleic Acids Res.,
October 19, 2004;
32(18):
5668 - 5676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fujimoto, H. Takeuchi, B. Taback, E. C. Hsueh, D. Elashoff, D. L. Morton, and D. S. B. Hoon
Allelic Imbalance of 12q22-23 Associated with APAF-1 Locus Correlates with Poor Disease Outcome in Cutaneous Melanoma
Cancer Res.,
March 15, 2004;
64(6):
2245 - 2250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Hopkins, X. Wang, A. Berlin, H. Hang, H. M. Thaker, and H. B. Lieberman
Expression of Mammalian Paralogues of HRAD9 and Mrad9 Checkpoint Control Genes in Normal and Cancerous Testicular Tissue
Cancer Res.,
September 1, 2003;
63(17):
5291 - 5298.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|